Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2010
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754722 Piperazine derivatives and methods of use
07/13/2010US7754721 Arylpiperazine derivatives and uses thereof
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754654 Substituted spirocyclic ketoenols
07/13/2010CA2539546C Isoquinoline potassium channel inhibitors
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same
07/13/2010CA2368582C Pesticidal triazine derivatives
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077275A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010WO2010076524A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
07/08/2010WO2010075962A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
07/08/2010WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication
07/08/2010WO2010045575A3 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
07/08/2010WO2010012806A3 Substituted indole sulfonamide compounds, their preparation and use as medicaments
07/08/2010WO2010009139A3 Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
07/08/2010US20100174088 Process for the preparation of benzimidazol thienylamine compounds and derivatives thereof useful as sodium/proton exchanger type 3 inhibitors
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
07/08/2010US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2747641A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
07/08/2010CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators
07/08/2010CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/07/2010EP2203437A1 Chiral cis-imidazolines
07/07/2010EP2203431A1 Anti-infective pyrimidines and uses thereof
07/07/2010EP2203430A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP2203427A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
07/07/2010EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
07/07/2010EP1861380B1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101772496A Substituted oxazolidinones and the use thereof
07/07/2010CN101772495A fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
07/07/2010CN101772487A Novel compounds
07/07/2010CN101768151A 2-(2-pyridyl)-8-sulfonamidoquinoline derivative, synthesis method and application thereof
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/06/2010USRE41425 Piperazine and piperidine compounds
07/06/2010US7750161 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists
07/06/2010US7750040 G protein-coupled receptor S1P1/EDG1 agonists; low dosage, long lasting immunosuppressive effect; such as 1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid 2,4-dimethoxy-benzylamide
07/06/2010US7750037 Antidepressant
07/06/2010US7750025 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
07/06/2010US7750023 Quinuclidine derivatives and medicinal compositions containing the same
07/06/2010US7750011 Diazabicyclic aryl derivatives and their medical use
07/06/2010US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010075287A2 Compounds and methods for the treatment of pain and other diseases
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010075090A2 Scopine modulators of muscarinic acetylcholine receptor
07/01/2010WO2010074751A1 Stable sulfoximine-insecticide compositions
07/01/2010WO2010074747A1 Stable insecticide compositions and methods for producing same
07/01/2010WO2010074607A2 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074219A1 Benzothiophen compound
07/01/2010WO2010074101A1 Aminopyridine compound and use of same
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010072599A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010WO2010046912A3 Thiophene containing analogues of fluconazole as antifungal agents and process for their preparation
07/01/2010WO2010036921A3 Slow release of organoboronic acids in cross-coupling reactions
07/01/2010US20100168418 Novel nitrogenated heterocyclic compound and salt thereof
07/01/2010US20100168189 Therapeutic substituted lactams
07/01/2010US20100168183 Subsituted cyclic compound, its preparation process and its medical use
07/01/2010US20100168176 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
07/01/2010US20100168175 Atpenins
07/01/2010US20100168132 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
07/01/2010US20100168104 Hiv inhibiting 5-amido substituted pyrimidines
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168070 Compounds for the treatment of alzheimer's disease
07/01/2010US20100168066 Novel insecticides
07/01/2010US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
07/01/2010US20100166850 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
07/01/2010US20100166765 Benzoquinazoline derivatives
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
07/01/2010US20100163852 Material for light-emitting device and light-emitting device
07/01/2010CA2748133A1 Stable sulfoximine-insecticide compositions
07/01/2010CA2748132A1 Stable insecticide compositions and methods for producing same
07/01/2010CA2748124A1 Ppar agonist compositions and methods of use
07/01/2010CA2747957A1 Compounds and methods for the treatment of pain and other diseases
07/01/2010CA2747795A1 Isoquinoline derivative
07/01/2010CA2745866A1 Dihydropyridone ureas as p2x7 modulators
06/2010
06/30/2010EP2202231A1 2,3-dihydroiminoisoindole derivative
06/30/2010EP2201001A1 Novel imidazole derivatives
06/30/2010EP2201000A1 Novel imidazole derivatives
06/30/2010EP2200990A1 Gamma secretase modulators
06/30/2010EP1673349B1 Benzimidazole derivatives: preparation and pharmaceutical applications
06/30/2010EP1558572B1 Novel compounds and their use as prar-modulators
06/30/2010EP1476435B1 Novel pyridin- and pyrimidin-derivatives